Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
THYROCARE.NSthis companyThyrocare Technologies Limited	₹485.30	34.04×	9.48×	6.69×	20.95×	-16.7%	37.4%	25.0%	19.7%	27.8%	24.4%	3.5%	0.09×	0.05×	73.89×	3.39×	2.7%	5	29.38	3	B+
KRSNAA.NSKrsnaa Diagnostics Limited	₹493.60	16.62×	1.72×	2.18×	8.58×	-320.3%	39.0%	15.7%	13.1%	10.3%	5.9%	-5.6%	0.55×	1.98×	3.53×	2.68×	0.5%	3	—	2	B-
LALPATHLAB.NSDr. Lal PathLabs Limited	₹2,016.50	43.39×	8.73×	7.93×	25.61×	4.3%	42.0%	22.5%	18.3%	20.1%	16.9%	2.4%	0.08×	-0.05×	27.22×	3.48×	1.0%	4	—	2	C+
METROPOLIS.NSMetropolis Healthcare Limited	₹582.35	47.23×	5.93×	5.45×	21.92×	69.1%	47.8%	16.2%	11.5%	12.6%	10.4%	3.3%	0.15×	0.42×	10.88×	1.4×	0.2%	4	—	2	C+
VIJAYA.NSVijaya Diagnostic Centre Limited	₹1,478.30	52.62×	9.51×	11.18×	26.51×	-44.7%	88.4%	30.1%	21.2%	18.1%	13.0%	1.0%	0.44×	1.07×	7.38×	2.6×	0.2%	3	—	2	C+
VIMTALABS.NSVimta Labs Limited	₹504.50	21.88×	3.71×	4.16×	11.42×	-54.3%	38.9%	24.4%	19.0%	17.0%	14.9%	2.9%	0.01×	-0.43×	85.09×	3.43×	0.3%	3	—	2	C+
Peer median	—	43.39×	5.93×	5.45×	21.92×	-44.7%	42.0%	22.5%	18.3%	17.0%	13.0%	2.4%	0.15×	0.42×	10.88×	2.68×	0.3%	3	—	2	—